195 related articles for article (PubMed ID: 29082557)
1. The nuclear DEK interactome supports multi-functionality.
Smith EA; Krumpelbeck EF; Jegga AG; Prell M; Matrka MM; Kappes F; Greis KD; Ali AM; Meetei AR; Wells SI
Proteins; 2018 Jan; 86(1):88-97. PubMed ID: 29082557
[TBL] [Abstract][Full Text] [Related]
2. Bacterial Growth Inhibition Screen (BGIS) identifies a loss-of-function mutant of the DEK oncogene, indicating DNA modulating activities of DEK in chromatin.
Guo H; Prell M; Königs H; Xu N; Waldmann T; Hermans-Sachweh B; Ferrando-May E; Lüscher B; Kappes F
FEBS Lett; 2021 May; 595(10):1438-1453. PubMed ID: 33686684
[TBL] [Abstract][Full Text] [Related]
3. High-affinity interaction of poly(ADP-ribose) and the human DEK oncoprotein depends upon chain length.
Fahrer J; Popp O; Malanga M; Beneke S; Markovitz DM; Ferrando-May E; Bürkle A; Kappes F
Biochemistry; 2010 Aug; 49(33):7119-30. PubMed ID: 20669926
[TBL] [Abstract][Full Text] [Related]
4. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
[TBL] [Abstract][Full Text] [Related]
5. The unique DEK oncoprotein in women's health: A potential novel biomarker.
de Albuquerque Oliveira AC; Kappes F; Martins DBG; de Lima Filho JL
Biomed Pharmacother; 2018 Oct; 106():142-148. PubMed ID: 29957464
[TBL] [Abstract][Full Text] [Related]
6. DEK is required for homologous recombination repair of DNA breaks.
Smith EA; Gole B; Willis NA; Soria R; Starnes LM; Krumpelbeck EF; Jegga AG; Ali AM; Guo H; Meetei AR; Andreassen PR; Kappes F; Vinnedge LM; Daniel JA; Scully R; Wiesmüller L; Wells SI
Sci Rep; 2017 Mar; 7():44662. PubMed ID: 28317934
[TBL] [Abstract][Full Text] [Related]
7. DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress.
Kappes F; Fahrer J; Khodadoust MS; Tabbert A; Strasser C; Mor-Vaknin N; Moreno-Villanueva M; Bürkle A; Markovitz DM; Ferrando-May E
Mol Cell Biol; 2008 May; 28(10):3245-57. PubMed ID: 18332104
[TBL] [Abstract][Full Text] [Related]
8. Solution NMR structure of the N-terminal domain of the human DEK protein.
Devany M; Kappes F; Chen KM; Markovitz DM; Matsuo H
Protein Sci; 2008 Feb; 17(2):205-15. PubMed ID: 18227428
[TBL] [Abstract][Full Text] [Related]
9. The Complexity of DEK Signaling in Cancer Progression.
Teng Y; Lang L; Jauregui CE
Curr Cancer Drug Targets; 2018; 18(3):256-265. PubMed ID: 28530531
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.
Kappes F; Damoc C; Knippers R; Przybylski M; Pinna LA; Gruss C
Mol Cell Biol; 2004 Jul; 24(13):6011-20. PubMed ID: 15199154
[TBL] [Abstract][Full Text] [Related]
11. Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.
Karam M; Thenoz M; Capraro V; Robin JP; Pinatel C; Lancon A; Galia P; Sibon D; Thomas X; Ducastelle-Lepretre S; Nicolini F; El-Hamri M; Chelghoun Y; Wattel E; Mortreux F
Neoplasia; 2014 Jan; 16(1):21-30. PubMed ID: 24563617
[TBL] [Abstract][Full Text] [Related]
12. Secreted nuclear protein DEK regulates hematopoiesis through CXCR2 signaling.
Capitano ML; Mor-Vaknin N; Saha AK; Cooper S; Legendre M; Guo H; Contreras-Galindo R; Kappes F; Sartor MA; Lee CT; Huang X; Markovitz DM; Broxmeyer HE
J Clin Invest; 2019 May; 129(6):2555-2570. PubMed ID: 31107242
[TBL] [Abstract][Full Text] [Related]
13. The DEK oncoprotein binds to highly and ubiquitously expressed genes with a dual role in their transcriptional regulation.
Sandén C; Järvstråt L; Lennartsson A; Brattås PL; Nilsson B; Gullberg U
Mol Cancer; 2014 Sep; 13():215. PubMed ID: 25216995
[TBL] [Abstract][Full Text] [Related]
14. DEK over-expression promotes mitotic defects and micronucleus formation.
Matrka MC; Hennigan RF; Kappes F; DeLay ML; Lambert PF; Aronow BJ; Wells SI
Cell Cycle; 2015; 14(24):3939-53. PubMed ID: 25945971
[TBL] [Abstract][Full Text] [Related]
15. Intercellular trafficking of the nuclear oncoprotein DEK.
Saha AK; Kappes F; Mundade A; Deutzmann A; Rosmarin DM; Legendre M; Chatain N; Al-Obaidi Z; Adams BS; Ploegh HL; Ferrando-May E; Mor-Vaknin N; Markovitz DM
Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6847-52. PubMed ID: 23569252
[TBL] [Abstract][Full Text] [Related]
16. The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival.
Hacker KE; Bolland DE; Tan L; Saha AK; Niknafs YS; Markovitz DM; McLean K
Neoplasia; 2018 Dec; 20(12):1209-1218. PubMed ID: 30412857
[TBL] [Abstract][Full Text] [Related]
17. Functional domains of the ubiquitous chromatin protein DEK.
Kappes F; Scholten I; Richter N; Gruss C; Waldmann T
Mol Cell Biol; 2004 Jul; 24(13):6000-10. PubMed ID: 15199153
[TBL] [Abstract][Full Text] [Related]
18. DEK oncoprotein participates in heterochromatin replication via SUMO-dependent nuclear bodies.
Pierzynska-Mach A; Czada C; Vogel C; Gwosch E; Osswald X; Bartoschek D; Diaspro A; Kappes F; Ferrando-May E
J Cell Sci; 2023 Dec; 136(23):. PubMed ID: 37997922
[TBL] [Abstract][Full Text] [Related]
19. The PML-associated protein DEK regulates the balance of H3.3 loading on chromatin and is important for telomere integrity.
Ivanauskiene K; Delbarre E; McGhie JD; Küntziger T; Wong LH; Collas P
Genome Res; 2014 Oct; 24(10):1584-94. PubMed ID: 25049225
[TBL] [Abstract][Full Text] [Related]
20. The human oncoprotein and chromatin architectural factor DEK counteracts DNA replication stress.
Deutzmann A; Ganz M; Schönenberger F; Vervoorts J; Kappes F; Ferrando-May E
Oncogene; 2015 Aug; 34(32):4270-7. PubMed ID: 25347734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
